We are on a mission to improve patient outcomes
We create novel medicines that benefit patients in need
About ResoTher Pharma
We target neutrophil driven inflamation and act as resolution therapy
ResoTher Pharma is a privately held biotechnology company located in Copenhagen, Denmark. The company is focused on discovering and developing peptide-based drugs as resolution therapy for diseases where inflammation plays a key pathological role.
ResoTher Pharma initiates dosing in its Phase 2a clinical trial in myocardial infarction patients
ResoTher Pharma is pleased to announce that the first patient [...]
ResoTher Pharma: Improving Cardiovascular Outcomes
Please read our biography published in Life Sciences Review 'Company [...]
ResoTher Pharma receives a €2.5 million grant from the European Innovation Council
ResoTher Pharma, a biotech company focused on developing life-saving [...]
Latest News
ResoTher Pharma initiates dosing in its Phase 2a clinical trial in myocardial infarction patients
ResoTher Pharma is pleased to announce that the first patient [...]
ResoTher Pharma: Improving Cardiovascular Outcomes
Please read our biography published in Life Sciences Review 'Company [...]
ResoTher Pharma receives a €2.5 million grant from the European Innovation Council
ResoTher Pharma, a biotech company focused on developing life-saving [...]
